Addressing the challenges faced by Global Medical Affairs teams and how they can find balance to create maximum value for their organizations.
Erin O'Hare
Advertisement
Articles by Erin O'Hare
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
3
Eli Lilly Enters $1.2 Billion Definitive Agreement to Acquire Ventyx Biosciences
4
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
5